摘要:
Disclosed is a novel adamantine derivative compound, an isomer thereof, pharmaceutically acceptable salt thereof, prodrug thereof, hydrate thereof or a solvate thereof. Also disclosed is a method for preparing a novel adamantine derivative compound, an isomer thereof, pharmaceutically acceptable salt thereof, prodrug thereof, hydrate thereof or a solvate thereof. The novel adamantane derivative compound or the like has an excellent anti-androgenic effect.
摘要:
The invention relates to a method for producing isocyanates by reacting primary amines with phosgene in a solvent, the solvent containing a dialkyl carbonate.
摘要:
Degradable isocyanate compounds, methods for making these compounds, and uses of these compounds for preparing degradable cross-linked polymers and composite materials are provided.
摘要:
The invention relates to novel isocyanate and isothiocyanate compounds, pharmaceutical compositions comprising same, and the use thereof for the treatment of cancer in humans and animals. Compared with previously known isocyanate and isothiocyanate compounds, the novel isocyanate and isothiocyanate compounds are characterized by greater therapeutic breadth, i.e. fewer side effects and high antitumor activity.
摘要:
Die Erfindung betrifft ein Verfahren zur Herstellung von Isocyanaten in einem Anlagenverbund umfassend eine Isocyanat-Produktionsanlage, eine Chlor-Produktionsanlage und eine Phosgen-Produktionsanlage, bei dem als Nebenprodukt gebildetes Kohlenstoffdioxid teilweise bis vollständig mit dem in der Chlor-Produktionsanlage gebildeten gasförmigen Chlor auskondensiert wird, in den Phosgen-Herstellungsprozess gelangt und dadurch nach der Phosgenherstellung der überwiegende Teil des gebildeten Kohlenstoffdioxids gasförmig aus dem Anlagenverbund ausgeschleust wird.
摘要:
The present invention relates to 1H-Quinazoline-2,4-diones of formula (I)
wherein R 1 and R 2 are as defined in the specification, their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them. Further, intermediates for the manufacture of compounds of formula (I) are and combinations comprising compounds of formula (I) are disclosed.
摘要:
The present invention relates to 1H-Quinazoline-2,4-diones of formula (I)
wherein R 1 and R 2 are as defined in the specification, their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them. Further, intermediates for the manufacture of compounds of formula (I) are and combinations comprising compounds of formula (I) are disclosed.
摘要:
The invention relates to a method for producing isocyanates by reacting the corresponding primary amines with phosgene in an inert solvent, while using 0.01 to 50 mole percent of a sulfoxide, a sulfone or mixtures thereof, based on the total quantity of the primary amine and isocyanate produced in the reaction solution.